Kate Winslet condemns the alarming and harmful rise of plastic surgery, speaks out against weight loss medications.
Kate Winslet Critiques Cosmetic Surgery Trends Kate Winslet has voiced her strong disapproval of “horrible” cosmetic surgery and weight-loss drugs, expressing concern that young women today have a skewed understanding of beauty. The Titanic actress, now 50, underscored how such procedures can profoundly alter a woman’s appearance, remarking, “Oh, that’s scary.” She elaborated, stating, “This […]
First official advice on GLP-1 medications for treating obesity is published.
WHO Releases Guidance on GLP-1 Drugs for Obesity Treatment The World Health Organization (WHO) has published new guidelines regarding the use of GLP-1 drugs for managing obesity. GLP-1 medications are designed to imitate the effects of the natural hormone glucagon-like peptide 1 and are mainly used in treating type 2 diabetes and aiding in weight […]
Medicare is working to lower prices on 15 commonly used medications. Will you save money?
Medicare Drug Price Negotiations: What’s at Stake for Seniors The Trump administration is working on lowering prices for 15 common drugs included in Medicare coverage. The government estimates this action will cut spending on these medications by about 44%, which translates to around $12 billion. But, will this really lead to savings for seniors? It’s […]
Weight loss medications are ruining Thanksgiving by eliminating sugar and butter too
Thanksgiving Shifts as Families Adapt to Health Trends Thanksgiving is shaping up to be quite different this year for many families, especially those dealing with nutrition and health changes. For new moms, like Jennifer Stojkovic, whose son Roman was born in September, the holiday presents both a craving for comfort food and a challenge. With […]
Managing holiday meals while using GLP-1 weight-loss medications
Impact of GLP-1 Weight Loss Medications on Social Interactions GLP-1 medications can aid in weight loss and support blood sugar control, but they also have the potential to alter social interactions significantly. As the holiday season draws near, those taking obesity medications may struggle with family meals or larger gatherings. This is largely due to […]
Study in the UK Will Allow Children as Young as Ten to Receive Puberty-Blocking Medications
Clinical Trials for Transgender Drugs in Children Underway in the UK In the UK, children aged 10 and older are set to participate in clinical trials involving transgender medications, despite the government’s prohibition on the public use of puberty blockers. Last year, a prominent study led by pediatrician Dr. Hilary Cass suggested that the practice […]
GLP-1 medications might allow colon cancer patients to have a longer life, research suggests
Study Links GLP-1 Drugs to Longer Lives for Colon Cancer Patients A recent study indicates that colon cancer patients could experience longer lifespans if they use GLP-1 medications, including Ozempic and Wegovy. Researchers from the University of California, San Diego examined over 6,800 patients who were prescribed these common diabetes and weight-loss drugs. The results […]
What is the price of well-known obesity medications?
President Donald Trump announced a new agreement on Thursday that aims to make weight-loss drugs like Wegovy and Zepbound more affordable for Americans. This deal with drug manufacturers Novo Nordisk and Eli Lilly could reduce the price of GLP-1 medications to as low as $149 a month. Currently, these popular injections start at around $350 […]
Musk’s $1 trillion compensation, a reduction for obesity medications, Target’s store challenges, and more in Morning Squawk.
Here’s a snapshot of key developments that might interest investors as they kick off their trading day. 1. A $1 trillion compensation plan The world’s wealthiest individuals are poised to increase their fortunes. Yesterday, shareholders backed Elon Musk’s almost $1 trillion compensation package, with around 75% supporting it despite pushback from prominent proxy advisors. This […]
Trump reaches significant agreement with pharmaceutical companies Lilly and Novo regarding obesity medications and Medicare.
Addressing America’s Obesity Crisis Robert F. Kennedy Jr., the Secretary of Health and Human Services, is currently focused on pinpointing the underlying reasons behind the obesity epidemic in the United States. At the same time, the Trump administration aims to ensure affordable access to medications for diabetes and weight loss, particularly targeting glucagon-like peptide-1 receptor […]